 
		      
  Have you ever wondered just what a stem cell really is? Or why your
  tax dollars fund stem cell research? Can stem cells cure a disease? Do
  we have the technology to clone ourselves? The rapidly growing field
  of stem cell biology holds the promise of enormous benefits for
  medicine and science, and is a platform for capital gains as well as
  many legal and ethical issues. This talk will address these questions
  and offer a viewpoint on how recent advents in stem cell biology will
  affect the future of stem cell research and medicine.
Millie (Mridula) is currently a 3rd year graduate student in the
			    Biological and Biomedical Sciences program at Harvard Medical School.
			    She is also an associate producer at an online media company,
			    BioBusiness.tv.  Recently (Summer 2009) she helped produce a 10-part
			    series on stem cells, interviewing key opinion leaders in academia,
			    finance, biotech and Pharma/medicine about the basics of stem cell
			    biology and the future of the field.  In her undergraduate research,
			    she worked for two years in a leading stem cell lab at MIT.  Her
			    current research involves characterizing the interactions of a group
		      of proteins which are essential to development.